Welcome to Medications.com

Analysis confirms antirheumatic potential to ease CV risks - Pharma Times (subscription)

At the same time, other studies have suggested that treating RA with DMARDs such as methotrexate or TNF-alpha blockers, may reduce this risk. ...

http://www.pharmatimes.com/Clinic... | Posted: Thu Mar 06 06:28:49 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea